LENZ Therapeutics, Inc Added to NASDAQ Composite Index.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.72 USD | -6.09% | -7.63% | 0.00% |
15/04 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
15/04 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 455M | |
+16.34% | 122B | |
+19.21% | 113B | |
+18.81% | 26.49B | |
-23.29% | 19.4B | |
-19.10% | 16.24B | |
-20.59% | 15.4B | |
-46.14% | 15.15B | |
+62.52% | 14.93B | |
+4.24% | 13.52B |
- Stock Market
- Equities
- LENZ Stock
- News LENZ Therapeutics, Inc.
- LENZ Therapeutics, Inc.(NasdaqGS: LENZ) added to NASDAQ Composite Index